Ruane Cunniff's GMED Position Overview
Ruane Cunniff (via Ruane, Cunniff & Goldfarb L.P.) currently holds 57,371 shares of Globus Medical, Inc. (GMED) worth $4.3 M, representing 0.07% of the portfolio. First purchased in 2026-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Ruane Cunniff has maintained this position in GMED for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 51,363 shares.
Analysis based on 13F filings available since 2013 Q2
Ruane Cunniff's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Ruane Cunniff
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +51,363 | Add 854.91% | 57,371 | $74.90 |
| Q1 2026 | +6,008 | New Buy | 6,008 | $86.16 |
Ruane Cunniff's Globus Medical Investment FAQs
Ruane Cunniff first purchased Globus Medical, Inc. (GMED) in Q1 2026, acquiring 6,008 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ruane Cunniff has held Globus Medical, Inc. (GMED) for 3 quarters since Q1 2026.
Ruane Cunniff's largest addition to Globus Medical, Inc. (GMED) was in Q3 2026, adding 57,371 shares worth $4.3 M.
According to the latest 13F filing for Q3 2026, Ruane Cunniff's firm, Ruane, Cunniff & Goldfarb L.P., owns 57,371 shares of Globus Medical, Inc. (GMED), valued at approximately $4.3 M.
As of the Q3 2026 filing, Globus Medical, Inc. (GMED) represents approximately 0.07% of Ruane Cunniff's publicly disclosed stock portfolio, making it one of their key holdings.
Ruane Cunniff's peak holding in Globus Medical, Inc. (GMED) was 57,371 shares, as reported at the end of Q3 2026.